0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Review |

Minor Salivary Gland Basal Cell Adenocarcinoma A Systematic Review and Report of a New Case

David W. Cuthbertson, MD1; Nikhila Raol, MD1; John Hicks, MD, DDS, PhD2; Linda Green, MD2,3; Robert Parke, MD1,3
[+] Author Affiliations
1Bobby R. Alford Department of Otolaryngology–Head and Neck Surgery, Baylor College of Medicine, Houston, Texas
2Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
3Michael E. Debakey Department of Veteran’s Affairs Medical Center, Houston, Texas
JAMA Otolaryngol Head Neck Surg. 2015;141(3):276-283. doi:10.1001/jamaoto.2014.3344.
Text Size: A A A
Published online

Importance  Basal cell adenocarcinoma (BCAC) of the minor salivary gland is an extremely rare disease: the most recent substantive literature review reports only 25 cases. Owing to the rarity of this disease, it has not yet been well characterized in the literature.

Objective  We sought to expand the knowledge of minor salivary gland BCAC by performing an exhaustive literature review and adding to it a new case that is rare owing to the tumor’s size, aggressive nature, and mixed histologic pattern. The review emphasizes epidemiologic patterns, diagnostic characteristics, treatment patterns, and expected prognosis for minor salivary gland BCAC.

Evidence Acquisition  In June 2012, PubMed was queried using the term “salivary gland basal cell adenocarcinoma,” and the resultant articles were reviewed. Those specifically mentioning a minor salivary gland BCAC were included in this study. Those that did not differentiate minor salivary gland BCAC from major salivary gland BCAC were excluded. The search was not limited by language and included articles from North America, Europe, Africa, and Asia from 1978 to June 2012.

Results  The PubMed search resulted in 195 articles, of which 33 articles reported at least 1 case of minor salivary gland BCAC. We report herein 72 cases of minor salivary gland BCAC (71 cases from the literature review and 1 new case reported herein). The mean patient age at the time of presentation was 56 years (range, 24-90 years), and the disease showed no sex predilection. The most common location was the palate, and the average lesions size was 2.4 cm (range, 0.7-4.2 cm). The treatment modality of choice was wide local excision (n = 57; 79%). There was a high local recurrence rate (n = 30; 41%) but a low rate of distant metastasis (n = 8; 11%).

Conclusions and Relevance  We present a comprehensive review of minor salivary gland BCAC, describing nearly 3 times as many cases as has been previously reported. This review characterizes a rare disease and increases awareness of the disease among otolaryngologists. Minor salivary gland BCAC is similar to major salivary gland BCAC and minor salivary gland tumors in general with regard to patient age, sex, tumor site, treatment modality, recurrence, metastasis, and mortality.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Place holder to copy figure label and caption
Figure 1.
Preoperative Maxillofacial Computed Tomographic Images With Contrast From the Present Case Report

A, Sagittal view shows the mass eroding through the hard palate (red arrowhead) and extending into pterygopalatine fossa (asterisk). B, Axial view shows the mass extending into the nasal cavity (plus sign) and pterygopalatine fossa (asterisk). In both panels, the tumor edges are marked with yellow arrowheads.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Hematoxylin-Eosin–Stained Specimens of Basal Cell Adenocarcinoma Involving the Palate From the Present Case Report

A and B, Tumor with tubular pattern composed of centrally placed large polygonal cells with a moderate amount of cytoplasm and peripherally placed smaller cells with modest amount of cytoplasm and dense nuclei (original magnification ×200 [A] and ×400 [B]). C, Prominent vascular invasion by tumor cells (arrowheads) (original magnification ×100). D, Perineural invasion by tumor cells (arrowheads) (original magnification ×200). E, Perineural invasion by tumor cells at higher magnification (original magnification ×400). F, Tumor invading between reactive bone trabeculae (original magnification ×200). G, Tumor invading skeletal muscle (original magnification ×200). H, Tumor infiltrating adjacent nonneoplastic minor salivary gland lobule; note the absence of a tumor capsule (original magnification ×100). In all panels where they appear, N indicates nerve fibers; S, skeletal muscle.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

504 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();